Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses

Antiviral Res. 2020 Jun;178:104805. doi: 10.1016/j.antiviral.2020.104805. Epub 2020 Apr 21.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents*
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Humans
  • Ivermectin
  • Pandemics
  • Pneumonia, Viral
  • SARS Virus*
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Ivermectin